Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term

Company Overview - QuidelOrtho Corporation, based in San Diego, CA, specializes in in-vitro diagnostics technologies for point-of-care settings, clinical labs, and transfusion medicine, selling products directly to end users and distributors [11] Investment Ratings - QuidelOrtho is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating a solid overall performance [12] - The company has a Momentum Style Score of B, with shares increasing by 7.1% over the past four weeks [12] Earnings Estimates - Two analysts have revised their earnings estimates higher for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.01 to$2.35 per share [12] - QuidelOrtho has an average earnings surprise of 70.8%, suggesting strong performance relative to expectations [12] Investment Considerations - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, QuidelOrtho is recommended for investors' consideration [13]